Gaois

Search direction

Search mode

Filter results

Collections

15 results in 9 documents

  1. #2626929

    ag aithint go raibh dea-tionchar uilíoch ar an iomlán ag an tSaoráid um Rochtain Dhomhanda ar Vacsaín COVID-19 (COVAX), saoráid ar bhain roinnt dúshláin cur chun feidhme agus laigí di i rith an phróisis, agus á chur in iúl gur geal léi an dea-thionchar sin; ag tabhairt dá haire, faoi lár mhí an Mhárta 2022, go raibh os cionn 1,3 billiún dáileog curtha ar fáil ag COVAX do 144 thír agus gur saor in aisce a deonaíodh os cionn 500 milliún dáileog díobh sin; ag tabhairt dá haire, faoi lár mhí an Mhárta 2022, go raibh os cionn 400 milliún dáileog roinnte ag na Ballstáit; ag tabhairt dá haire gur chuir ganntanas soláthair bac ar thionchar COVAX, rud a d’fhág nárbh fhéidir le COVAX an sprioc a bhí aige le haghaidh 2021 a bhaint amach;

    Acknowledges and welcomes the overall positive global impact of COVID-19 Vaccines Global Access (COVAX), which was marked by several implementation challenges and weaknesses throughout the process; notes that by mid-March 2022, COVAX had delivered over 1,3 billion doses to 144 countries, of which over 500 million doses were donations; notes that by mid-March 2022 the Members States had shared over 400 million doses; notes that the impact of COVAX has been hindered by supply shortages, which prevented COVAX from meeting its target for 2021;

    Resolution (EU) 2022/1714 of the European Parliament of 4 May 2022 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the eighth, ninth, tenth and eleventh European Development Funds for the financial year 2020

  2. #1939804

    Bunaithe ar phrionsabal na dlúthpháirtíochta idirnáisiúnta, chun forálacha soláthairtí a chumasú i gcomhthéacs na freagartha práinne daonnúla, onnmhairí chuig saoráidí COVAX, agus go háirithe chuig tíortha ar ioncam íseal agus meánioncaim i bhfianaise a gcuid leochaileachta agus an rochtain theoranta atá acu ar vacsaíní, onnmhairí vacsaíní COVID-19 a cheannaítear nó a sheachadtar trí COVAX, UNICEF agus PAHO a bhfuil a gceann scríbe in aon tír eile atá rannpháirteach in COVAX agus onnmhairithe vacsaíní COVID-19 a cheannaigh Ballstáit faoi APAanna an Aontais agus a d’athdhíol nó a dheonaigh iad chuig tríú tíortha, ba cheart go ndíolmhófaí iad ó cheanglas an Aontais maidir le honnmhairiú.

    Based on the principle of international solidarity, exports to enable the provisions of supplies in the context of humanitarian emergency response, exports to the COVAX facilities, and in particular to low and middle-lower income countries, given their vulnerability and limited access to vaccines, exports of COVID-19 vaccines purchased or delivered through COVAX, Unicef and PAHO with destination to any other COVAX participating country and exports of COVID-19 vaccines purchased by Member States under the Union’s APAs and resold or donated to a third country should be exempted from the export authorisation requirement.

    Commission Implementing Regulation (EU) 2021/442 of 11 March 2021 making the exportation of certain products subject to the production of an export authorisation

  3. #1939828

    onnmhairí chuig tíortha ísealioncaim agus meánioncaim atá i liosta COVAX an ghealltanais réamhcheannaigh (;

    exports to low- and middle-income countries in the COVAX AMC list;

    Commission Implementing Regulation (EU) 2021/442 of 11 March 2021 making the exportation of certain products subject to the production of an export authorisation

  4. #1939829

    onnmhairí earraí a cheannaítear agus/nó a sheachadtar trí COVAX, UNICEF agus PAHO, agus aon tír eile atá páirteach in COVAX ina ceann scríbe acu;

    exports of goods purchased or delivered through COVAX, Unicef and PAHO with destination to any other COVAX participating country;

    Commission Implementing Regulation (EU) 2021/442 of 11 March 2021 making the exportation of certain products subject to the production of an export authorisation

  5. #2635381

    Cuireadh EUR 1 bhilliún ar fáil chun vacsaíní a cheannach trí Shaoráid COVAX.

    EUR 1 billion was made available to purchase vaccines through the COVAX Facility.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2021

  6. #2626066

    leanúint de thacaíocht a thabhairt don chlár COVAX chun dlús a chur le vacsaíniú i gcoinne COVID-19 i dtíortha i mbéal forbartha;

    continue to support the COVAX programme in order to speed up vaccination against COVID-19 in developing countries;

    Resolution (EU) 2022/1697 of the European Parliament of 4 May 2022 with observations forming an integral part of the decisions on discharge in respect of the implementation of the general budget of the European Union for the financial year 2020, Section III – Commission and executive agencies

  7. #2635379

    Sholáthair na Ballstáit 4.2 milliún dáileog de vacsaíní COVID-19 ar fáil, agus tugadh 2.2 milliún trí COVAX sna Balcáin Thiar.

    million doses of COVID-19 vaccines were provided by Member States, and 2.2 million through COVAX in the western Balkans.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2021

  8. #2637601

    Tá an tAontas fós ar an deontóir is mó vacsaíní COVID-19 ar fud an domhain, agus dáileoga a chomhroinneann na Ballstáit trí COVAX (an tSaoráid um Rochtain Dhomhanda ar Vacsaín COVID-19) agus mar dheontais dhéthaobhacha á gcur san áireamh.

    The EU remains the biggest donor of COVID-19 vaccines globally, considering doses shared by Member States via COVAX (COVID-19 Vaccines Global Access) and as bilateral donations.

    COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU response to COVID-19: preparing for autumn and winter 2023

  9. #2637607

    D’fhógair an tAontas tacaíocht bhreise EUR 375 mhilliún do thíortha a bhfuil na rátaí vacsaínithe is ísle acu trí shásra Tacaíochta Seachadta COVID-19 de chuid Shaoráid COVAX.

    The EU has announced additional EUR 375 million support to countries with the lowest vaccination rates through the COVID-19 Delivery Support mechanism of the COVAX Facility.

    COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU response to COVID-19: preparing for autumn and winter 2023

  10. #3060380

    Ar fud an domhain, tá an tAontas ar cheann de na príomhdheontóirí in COVAX, saoráid rochtana domhanda na vacsaíne COVID-19.

    Globally, the EU is one of the lead donors in COVAX, the COVID-19 vaccine global access facility.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU Voluntary Review on progress in the implementation of the 2030 Agenda for Sustainable Development

  11. #2373788

    Ina gcomharsanacht chomhchoiteann agus níos faide i gcéin, neartóidh an tAontas Eorpach agus an Éigipt an comhar agus comhairliúcháin agus malartú taithí maidir le bainistiú agus cosc géarchéime, ar bhonn déthaobhach agus réigiúnach araon, lena n-áirítear trí bhíthin Ionad Idirnáisiúnta Chaireo um Réiteach Coinbhleacht, Síochánaíocht agus Cothú na Síochána (CCCPA), chun aghaidh a thabhairt ar na dúshláin chasta atá ann don tsíocháin, don chobhsaíocht agus don fhorbairt, ar dúshláin iad a eascraíonn as coinbhleacht, as an athrú aeráide, as tubaistí nádúrtha agus as eipidéimí, lena n-áirítear trí COVAX.

    The EU and Egypt will step up cooperation and consultations and the exchange of experience in crisis management and prevention, both bilaterally and regionally, including through the Cairo International Center for Conflict Resolution, Peacekeeping and Peacebuilding (CCCPA), to address the complex challenges to peace, stability and development arising from conflict, climate change, natural disasters and epidemics, including through COVAX, in their common neighbourhood and beyond.

    Recommendation No 1/2022 of the EU-Egypt Association Council of 19 June 2022 on the EU-Egypt Partnership Priorities 2021–2027 [2022/1101]

  12. #2626832

    ag moladh “Foireann na hEorpa” as rannchuidiú EUR 850000000 a dhéanamh le COVAX, tionscnamh vacsaíne domhanda; á chur i bhfáth gur bhain an tAontas leas as a chumhacht chomórtha chun cistiú agus gealltanais a dhaingniú ar fud an domhain i gcomhair rochtain ar chosc, ar thástálacha diagnóise agus ar chóireáil i gcoinne COVID-19, lena n-áirítear tríd an gComhdháil Gealltanais maidir leis an bhFreagairt Dhomhanda ar an gCoróinvíreas, agus go ndearna sé EUR 1,4 billiún a ghealladh don cholún freagartha COVID-19 sin i bhfoirm deontas agus ráthaíochtaí;

    Applauds that ‘Team Europe’ contributed EUR 850000000 to COVAX, the global vaccine initiative; stresses that the Union used its convening power to secure funding and commitment across the world for universal access to prevention, diagnosis tests and treatment against COVID-19, including through the Coronavirus Global Response Pledging Conference, and it pledged EUR 1,4 billion to this COVID-19 response pillar in the form of grants and guarantees;

    Resolution (EU) 2022/1712 of the European Parliament of 4 May 2022 with observations forming an integral part of the decision on discharge in respect of the implementation of the general budget of the European Union for the financial year 2020, Section X – European External Action Service

  13. #2635359

    Chuidigh cur chuige Fhoireann na hEorpa leis an Aontas agus a Bhallstáit sa mhéid gurbh iad an deontóir ba mhó do thionscnamh Rochtain Dhomhanda ar Vacsaíní COVID-19 (COVAX) in 2021 iad agus breis agus EUR 3 bhilliún soláthartha chun vacsaíní COVID-19 a cheannach.

    The Team Europe approach has helped the EU and its Member States to become the biggest donor to the COVID-19 Vaccines Global Access (COVAX) initiative in 2021 with over EUR 3 billion provided for the purchase of COVID-19 vaccines.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2021

  14. #3048194

    á chur i bhfios go láidir gur bealach í tacaíocht bhuiséadach an Aontais chun cúnamh éifeachtach a chur ar fáil, lena n-áirítear i gcásanna géarchéime, agus gur cuidiú í chun córais na dtíortha agus na próisis bhuiséid le haghaidh beartais phoiblí a chur chun feidhme agus torthaí inbhuanaithe a bhaint amach a neartú; á mheabhrú go bhfuil tábhacht ag baint leis an tSaoráid um Rochtain Dhomhanda ar Vacsaín COVID-19 (COVAX) a choinneáil chun an seans a uasmhéadú go bhfaighidh daoine i dtíortha rannpháirteacha rochtain ar vacsaíní COVID-19 agus vacsaíní eile i gcás géarchéim nua chomh luath, chomh cothrom agus chomh sábháilte agus is féidir; á chur i bhfáth, thairis sin, go raibh ról lárnach aici le linn phaindéim COVID-19 sa mhéid gur cuireadh spás fioscach breise ar fáil chun dul i ngleic le tionchar diúltach na paindéime; ag aithint gur cheart do na hiarrachtaí sin leanúint ar aghaidh go luath amach anseo i bhfianaise éifeachtaí uafásacha domhanda chogadh foghach na Rúise i gcoinne na hÚcráine;

    Underlines that Union budget support is a means to deliver effective assistance, including in situations of crisis, it helps strengthen country systems and budget processes to implement public policies and deliver sustainable results; recalls the importance of maintaining the COVID-19 Vaccines Global Access (COVAX) facility to maximise the chances of people in participating countries getting access to COVID-19 vaccines or other vaccines in the case of a new crisis situation as quickly, fairly and safely as possible; stresses, moreover, that it has been instrumental during the COVID-19 pandemic, offering additional fiscal space to tackle the negative impact of the pandemic; acknowledges that those efforts should continue in the near future in view of the devastating global effects of the Russian war of aggression against Ukraine;

    Resolution (EU) 2023/1842 of the European Parliament of 10 May 2023 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the eighth, ninth, tenth and eleventh European Development Funds for the financial year 2021

  15. #3060381

    Idir Samhain 2020 agus Meitheamh 2022, d’onnmhairigh an tAontas Eorpach breis agus 2.2 billiún dáileog vacsaíní chuig 167 tír san iomlán, ar deonaíodh 478 milliún dáileog díobh trí COVAX do thíortha a raibh gá acu leo, go háirithe ar fud na hAfraice.

    Between November 2020 and June 2022, the EU exported over 2.2 billion doses of vaccines to a total of 167 countries, of which 478 million doses were donated through COVAX to countries in need, particularly across Africa.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU Voluntary Review on progress in the implementation of the 2030 Agenda for Sustainable Development